CASP8 Gene

Last updated on: 27.05.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The CASP8 gene (CASP8 stands for "caspase 8") is a protein-coding gene located on chromosome 2q33.1. Many alternatively spliced transcript variants encoding different isoforms have been described, although full-length sequences have not been determined for all variants. For the isoforms listed below:

  • Isoform 5: Lacks the catalytic site and may affect the pro-apoptotic activity of the "death-inducing signaling complex (DISC)".
  • Isoform 6: Lacks the catalytic site and may impair the pro-apoptotic activity of the "death-inducing signaling complex (DISC)". CASP8_HUMAN,Q14790
  • Isoform 7: Lacks the catalytic site and may impair the pro-apoptotic activity of the "death-inducing signaling complex (DISC)". Acts as an inhibitor of the caspase cascade.
  • Isoform 8: Lacks the catalytic site and may impair the pro-apoptotic activity of the death-inducing signaling complex (DISC).

General informationThis section has been translated automatically.

The CASP8 gene encodes a member of the cysteine aspartic acid protease (caspase) family. Caspases (cysteinyl aspartate proteases) are involved in the signaling pathways of apoptosis, necrosis and inflammation. These enzymes can be divided into initiators and effectors. The initiator isoforms are activated by and interact with upstream adaptor molecules.

Caspases exist as inactive proenzymes consisting of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing on conserved internal aspartic acid residues to generate a heterodimeric enzyme consisting of the large and small subunits. This dimeric caspase enzyme is involved in programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with the Fas-interacting protein FADD.

PathophysiologyThis section has been translated automatically.

Caspase 8, encoded by the CASP8 gene, is a thiol protease that plays a key role in programmed cell death by acting as a molecular switch for:

  • Apoptosis
  • Necroptosis
  • Pyroptosis

. It is considered an initiator protease that induces extrinsic apoptosis by mediating the cleavage and activation of effector caspases responsible for TNFRSF6/FAS-mediated and TNFRSF1A-induced cell death. (Blasche S et al. 2013).

The encoded CASP8 protein cleaves and activates the effector caspases CASP3, CASP4, CASP6, CASP7, CASP9, and CASP10 . Binding to the adapter molecule FADD recruits it to either the receptor TNFRSF6/FAS or TNFRSF1A (Medema JP et al 1997). The resulting aggregate, termed thedeath-inducing signaling complex (DISC), carries out proteolytic activation of CASP8. The active dimeric enzyme is then released from the DISC and is free to activate downstream apoptotic proteases. In addition to extrinsic apoptosis, it also acts as a negative regulator of necroptosis: it cleaves RIPK1 at Asp-324, which is critical for inhibiting RIPK1 kinase activity and limits TNF-induced apoptosis, necroptosis, and inflammatory response (Tao P et al. 2020). May also induce pyroptosis by mediating the cleavage and activation of gasdermin-D (GSDMD): GSDMD cleavage promotes the release of the N-terminal component (gasdermin-D, N-terminal), which binds to membranes and forms pores, inducing pyroptosis.

Clinical pictureThis section has been translated automatically.

Diseases associated with CASP8 include autoimmune lymphoproliferative syndrome type 2b (caspase 8 deficiency) and hepatocellular carcinoma.

LiteratureThis section has been translated automatically.

  1. Blasche S et al. (2013) The E. coli effector protein NleF is a caspase inhibitor. PLoS One 8: e58937.
  2. Chun HJ et al (2002) Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419: 395-399.
  3. Madkaikar M et al (2011) Advances in autoimmune lymphoproliferative syndromes. Europ J Haemat. 87: 1-9.
  4. Medema JP et al (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16: 2794-2804.
  5. Puck JM et al (2004) Somatic mutations--not just for cancer anymore. New Eng J Med 351: 1388-1390.
  6. Tao P et al (2020) A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1. Nature 577(7788):109-114.
  7. Teachey DT et al (2009) Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS). Brit J Haemat 148: 205-216.
  8. Wu Y et al. (2016) Caspase-8 and Caspase-9 Functioned Differently at Different Stages of the Cyclic Stretch-Induced Apoptosis in Human Periodontal Ligament Cells. PLoS One 11: e0168268.

Last updated on: 27.05.2022